APOA1 and COVID-19: In the hyperinflammatory state, such as critical phase of COVID-19 with the acute elevation of tumor necrosis factor (TNF)-α and interleukin (IL)-6, serum concentrations of HDL-C and apoA-I significantly decreased and were negatively correlated with COVID-19 severity [6,7].